Announced Mon, 8 Sept · 16:18 IST

Intimation of Book Closure regrading 34th Annual General Meeting of the company

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Vista Pharmaceuticals has informed BSE about the book closure period for its 34th Annual General Meeting. The Register of Members and Share Transfer Books will remain closed from 24 September 2025 to 30 September 2025 (both days inclusive). The AGM is scheduled for Tuesday, 30 September 2025 at 11:00 AM and will be conducted through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The filing was made under Regulation 42 of the SEBI LODR Regulations, 2015. The intimation is signed by Executive Director Dhananjaya Alli (DIN: 00610909).

Likely market impact

This is a routine regulatory disclosure. No buying, selling, or transfer of shares will be permitted during the book closure window (24–30 September 2025). Shareholders holding shares as of the record date will be eligible to attend and vote at the AGM.